Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    05-23-2022 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-22-000054.pdf
    0001401914-22-000054.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    05-12-2022 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-22-000046.pdf
    0001401914-22-000046.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    05-12-2022 10-Q

    Quarterly report which provides a continuing view of a company's financial position

    View HTML
    0001401914-22-000051.pdf
    0001401914-22-000051.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    04-29-2022 DEF 14A

    Official notification to shareholders of matters to be brought to a vote ("Proxy")

    View HTML
    0001401914-22-000042.pdf
    0001401914-22-000042.xls
    04-29-2022 DEFA14A

    Additional proxy soliciting materials - definitive

    View HTML
    0001401914-22-000043.pdf
    0001401914-22-000043.xls
    04-15-2022 PRE 14A

    A preliminary proxy statement providing notification matters to be brought to a vote

    View HTML
    0001401914-22-000037.pdf
    0001401914-22-000037.xls
    03-31-2022 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-22-000022.pdf
    0001401914-22-000022.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    03-31-2022 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-22-000024.pdf
    0001401914-22-000024.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    03-31-2022 S-8

    Securities offered to employees pursuant to employee benefit plans

    View HTML
    0001401914-22-000033.pdf
    0001401914-22-000033.xls
    03-31-2022 10-K

    Annual report which provides a comprehensive overview of the company for the past year

    View HTML
    0001401914-22-000032.pdf
    0001401914-22-000032.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page Next ›
    • Last page Last »

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top